E Švandová - Concepedia

Author

E Švandová

Also Known As

E SVANDOVA, E Svandova, E Svandová, E Svandovă, E Švandová, E. SVANDOVA, E. Svandová, E. ŠVANDOVÁ, E. Švandová, Eva Svandova

168

Publications

992

Citations

H-Index

Concepts

All Affiliations

National Institute of Public Health National Institute Of Hygiene And Epidemiology Thomayer University Hospital Czech Academy of Sciences, Institute of Analytical Chemistry Charles University

EŠ

About

E Švandová is an author at National Institute of Public Health specializing in medicine, vaccination, and infection control.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	16	693
2	Public Health	4	4	61
3	Health Sciences	2	2	51
4	Allergy	2	2	71
5	Engineering	1	1	16

E Švandová

Publications

844

Citations

H-Index

Page 1

	Year	Citations
The development of clinical tuberculosis following infection with tubercle bacilli Ian Sutherland, E Švandová, S. Radhakrishna Tubercle Pulmonary TuberculosisTuberculosis PreventionPathologyTuberous SclerosisTuberculosis	1982	150
Diagnosis of Pleural Effusions Miloslav Marel, B Stástný, L Melínová, CHEST Journal Pleural EffusionsPneumothoraxDiagnosisPleural EffusionPleural Disease	1995	142
Six years' experience with the discontinuation of BCG vaccination L Trnka, D Dănkovã, E Švandová Tubercle and Lung Disease VaccinologyVaccine SafetyVaccinationBcg VaccinationVaccine Efficacy	1994	84
Endogenous reactivation and exogenous reinfection: their relative importance with regard to the development of non-primary tuberculosis. G Canetti, Ian Sutherland, E Švandová PubMed Pulmonary TuberculosisRelative ImportanceTuberculosis PreventionImmunologyPathogenesis	1972	62
Characterization of immunomodulatory polysaccharides from Salvia officinalis L. Peter Capek, Vĕra Hřı́balová, E Švandová, International Journal of Biological Macromolecules PolysaccharideImmunomodulatory PolysaccharidesAllergy	2003	61
Six years' experience with the discontinuation of BCG vaccination L Trnka, D Dănkovã, E Švandová Tubercle and Lung Disease VaccinologyVaccine SafetyVaccinationBcg VaccinationVaccine Efficacy	1993	57
Limitations of non‐invasive endothelial function assessment by brachial artery flow‐mediated dilatation T Šejda, Jan Piťha, E Švandová, Clinical Physiology and Functional Imaging	2005	41
Antimeningococcal herd immunity in the Czech Republic – influence of an emerging clone, <i>Neisseria meningitidis</i> ET-15/37 Paula Kriz, B Kříž, E Švandová, Epidemiology and Infection	1999	33
Chromosomal aberrations in peripheral lymphocytes of children as biomarkers of environmental exposure and life style Pavel Rössner, H Bavorová, Dana Očadlíková, Toxicology Letters CytogeneticsEnvironmental ExposureGeneticsEnvironmental HealthImmunology	2002	32
Six years' experience with the discontinuation of BCG vaccination L Trnka, D Dănkovã, E Švandová Tubercle and Lung Disease VaccinologyVaccine SafetyVaccinationBcg VaccinationVaccine Efficacy	1993	24

Page 1